207 related articles for article (PubMed ID: 34983784)
1. Antiangiogenesis: Vessel Regression, Vessel Normalization, or Both?
Augustin HG; Koh GY
Cancer Res; 2022 Jan; 82(1):15-17. PubMed ID: 34983784
[TBL] [Abstract][Full Text] [Related]
2. VEGF pathway targeting agents, vessel normalization and tumor drug uptake: from bench to bedside.
Arjaans M; Schröder CP; Oosting SF; Dafni U; Kleibeuker JE; de Vries EG
Oncotarget; 2016 Apr; 7(16):21247-58. PubMed ID: 26789111
[TBL] [Abstract][Full Text] [Related]
3. Antiangiogenic therapy: Markers of response, "normalization" and resistance.
El Alaoui-Lasmaili K; Faivre B
Crit Rev Oncol Hematol; 2018 Aug; 128():118-129. PubMed ID: 29958627
[TBL] [Abstract][Full Text] [Related]
4. Normalization of the vasculature for treatment of cancer and other diseases.
Goel S; Duda DG; Xu L; Munn LL; Boucher Y; Fukumura D; Jain RK
Physiol Rev; 2011 Jul; 91(3):1071-121. PubMed ID: 21742796
[TBL] [Abstract][Full Text] [Related]
5. Targeting tumor vascularization: promising strategies for vascular normalization.
Zheng R; Li F; Li F; Gong A
J Cancer Res Clin Oncol; 2021 Sep; 147(9):2489-2505. PubMed ID: 34148156
[TBL] [Abstract][Full Text] [Related]
6. Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy.
Jain RK
Science; 2005 Jan; 307(5706):58-62. PubMed ID: 15637262
[TBL] [Abstract][Full Text] [Related]
7. Antiangiogenic therapy for cancer: current and emerging concepts.
Jain RK
Oncology (Williston Park); 2005 Apr; 19(4 Suppl 3):7-16. PubMed ID: 15934498
[TBL] [Abstract][Full Text] [Related]
8. Apelin as a marker for monitoring the tumor vessel normalization window during antiangiogenic therapy.
Zhang L; Takara K; Yamakawa D; Kidoya H; Takakura N
Cancer Sci; 2016 Jan; 107(1):36-44. PubMed ID: 26475217
[TBL] [Abstract][Full Text] [Related]
9. Targeting activin receptor-like kinase 1 inhibits angiogenesis and tumorigenesis through a mechanism of action complementary to anti-VEGF therapies.
Hu-Lowe DD; Chen E; Zhang L; Watson KD; Mancuso P; Lappin P; Wickman G; Chen JH; Wang J; Jiang X; Amundson K; Simon R; Erbersdobler A; Bergqvist S; Feng Z; Swanson TA; Simmons BH; Lippincott J; Casperson GF; Levin WJ; Stampino CG; Shalinsky DR; Ferrara KW; Fiedler W; Bertolini F
Cancer Res; 2011 Feb; 71(4):1362-73. PubMed ID: 21212415
[TBL] [Abstract][Full Text] [Related]
10. The Pleiotropic Role of L1CAM in Tumor Vasculature.
Angiolini F; Cavallaro U
Int J Mol Sci; 2017 Jan; 18(2):. PubMed ID: 28134764
[TBL] [Abstract][Full Text] [Related]
11. Vascular-immuno-phenotypic (VIP) model for locally advanced and oligo-metastatic cancer: A hypothesis.
Swamy K
Med Hypotheses; 2021 Jul; 152():110618. PubMed ID: 34102599
[TBL] [Abstract][Full Text] [Related]
12. Lenalidomide normalizes tumor vessels in colorectal cancer improving chemotherapy activity.
Leuci V; Maione F; Rotolo R; Giraudo E; Sassi F; Migliardi G; Todorovic M; Gammaitoni L; Mesiano G; Giraudo L; Luraghi P; Leone F; Bussolino F; Grignani G; Aglietta M; Trusolino L; Bertotti A; Sangiolo D
J Transl Med; 2016 May; 14(1):119. PubMed ID: 27149858
[TBL] [Abstract][Full Text] [Related]
13. The Combination of Immune Checkpoint Blockade with Tumor Vessel Normalization as a Promising Therapeutic Strategy for Breast Cancer: An Overview of Preclinical and Clinical Studies.
Melaiu O; Vanni G; Portarena I; Pistolese CA; Anemona L; Pomella S; Bei R; Buonomo OC; Roselli M; Mauriello A; Barillari G
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834641
[TBL] [Abstract][Full Text] [Related]
14. Normalization of the tumor microenvironment by harnessing vascular and immune modulation to achieve enhanced cancer therapy.
Choi Y; Jung K
Exp Mol Med; 2023 Nov; 55(11):2308-2319. PubMed ID: 37907742
[TBL] [Abstract][Full Text] [Related]
15. Combination of antiangiogenesis with chemotherapy for more effective cancer treatment.
Ma J; Waxman DJ
Mol Cancer Ther; 2008 Dec; 7(12):3670-84. PubMed ID: 19074844
[TBL] [Abstract][Full Text] [Related]
16. Tumor angiogenesis and vascular normalization: alternative therapeutic targets.
Viallard C; Larrivée B
Angiogenesis; 2017 Nov; 20(4):409-426. PubMed ID: 28660302
[TBL] [Abstract][Full Text] [Related]
17. Recognition of tumor blood vessel normalization as a new antiangiogenic concept.
Hellmann K
Nat Med; 2004 Apr; 10(4):329; author reply 329-30. PubMed ID: 15057218
[No Abstract] [Full Text] [Related]
18. Antiangiogenic therapy for normalization of atherosclerotic plaque vasculature: a potential strategy for plaque stabilization.
Jain RK; Finn AV; Kolodgie FD; Gold HK; Virmani R
Nat Clin Pract Cardiovasc Med; 2007 Sep; 4(9):491-502. PubMed ID: 17712362
[TBL] [Abstract][Full Text] [Related]
19. Angiogenesis as a hallmark of solid tumors - clinical perspectives.
Majidpoor J; Mortezaee K
Cell Oncol (Dordr); 2021 Aug; 44(4):715-737. PubMed ID: 33835425
[TBL] [Abstract][Full Text] [Related]
20. Off-tumor target--beneficial site for antiangiogenic cancer therapy?
Cao Y
Nat Rev Clin Oncol; 2010 Oct; 7(10):604-8. PubMed ID: 20683436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
